Monograph Details
|
|
Cardiovascular System
> CHF and arrhythmias
|
|
SECTRAL |
| Manufacturer |
|
Dr. Reddy's Laboratories, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Cardioselective β-blocker. |
| Generic Name |
|
Acebutolol (as HCl) 200mg, 400mg; caps. |
| Indications |
|
Ventricular arrhythmias. |
| Children |
|
Not recommended. |
| Adults |
|
Initially 200mg twice a day. Usual range: 600mg–1.2g daily. |
| Elderly |
|
Max 800mg/day. |
| Contraindications |
|
Severe bradycardia. 2nd- or 3rd-degree AV block. Overt heart failure. Cardiogenic shock. |
| Precautions |
|
Bronchospastic disease. Ischemic heart disease or failure. Renal or hepatic dysfunction. Diabetes. Hyperthyroidism. Vascular insufficiency. Surgery. Avoid abrupt cessation. Elderly. Pregnancy (Cat.B). Nursing mothers: not recommended. |
| Interactions |
|
May potentiate hypotension with prazosin, reserpine, other catecholamine-depleting drugs. Antagonized by NSAIDs. May increase cardiac effects of verapamil, digitalis. Avoid α-adrenergic agonists. May block epinephrine. |
| Adverse Reactions |
|
Fatigue, dizziness, headache, GI upset, dyspnea, dysuria, insomnia, rash, myalgia, rhinitis, abnormal vision, hypotension, bradycardia, heart failure or block, bronchospasm, elevated ANA titers. |
| How Supplied |
|
Caps—100 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
